Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters
- 1 December 1990
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 19 (6) , 1539-1548
- https://doi.org/10.1016/0360-3016(90)90370-y
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intraperitoneal radioimmunotherapy for ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Macroscopic dosimetry for radioimmunotherapy: Nonuniform activity distributions in solid tumorsMedical Physics, 1989
- Dosimetry models for radioimmunotherapyMedical Physics, 1988
- The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantageCancer Immunology, Immunotherapy, 1988
- Intraperitoneal131I- and90-labelled monoclonal antibodies for ovarian cancer: Pharmacokinetics and normal tissue dosimetryInternational Journal of Cancer, 1988
- Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.Journal of Clinical Oncology, 1987
- A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Calculation of radiation doses for nonuniformly distributed β and γ radionuclides in soft tissueMedical Physics, 1985
- 211At radiocolloid therapy: Further observations and comparison with radiocolloids of 32P, 165Dy, and 90YInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Distribution of absorbed energy from a point beta-source in a tissue-equivalent mediumThe International Journal of Applied Radiation and Isotopes, 1972